Shanghai Suhao Yiming Pharmaceutical Co., Ltd. (a wholly-owned subsidiary of Anke Biotechnology), established in 2001, is a high-tech enterprise mainly engaged in research, development, production, and sales of various GMP peptide raw materials and drugs. Experimental and production facilities with international advanced level: fully automatic peptide synthesis system, separation and purification system, freeze-drying system and other instruments and equipment. On the basis of introducing, digesting, and absorbing international advanced peptide synthesis production technology, we have established a leading high-tech platform for the large-scale research and development of active small molecule peptide drugs and precursors in China. We have independently developed a unique solid-phase synthesis process route suitable for industrial production, providing peptide preparation enterprises at home and abroad with highly cost-effective and high-quality peptide raw materials. At present, there are more than 40 peptide active pharmaceutical ingredients that have been listed or are in the clinical stage both domestically and internationally. The breadth and production of the products are leading in China. The company provides high-quality peptide products, peptide purification services, peptide synthesis reagents, and technical consulting services to users.
Odor components | Odor inlet indicators | Odor discharge indicators | Exhaust pipe height |
H2S | ≤100mg/m3 | ≤0.6kg/h | 15m |
NH3 | ≤40mg/m3 | ≤0.6kg/h | |
C2H6S | ≤50mg/m3 | ≤0.6kg/h | |
Odour | ≤3000 | ≤800 |